PE56194A1 - ANALGESIC COMPOSITION - Google Patents

ANALGESIC COMPOSITION

Info

Publication number
PE56194A1
PE56194A1 PE1993233164A PE23316493A PE56194A1 PE 56194 A1 PE56194 A1 PE 56194A1 PE 1993233164 A PE1993233164 A PE 1993233164A PE 23316493 A PE23316493 A PE 23316493A PE 56194 A1 PE56194 A1 PE 56194A1
Authority
PE
Peru
Prior art keywords
analgesic composition
composition
ibuprofeno
flurbiprofeno
antipoda
Prior art date
Application number
PE1993233164A
Other languages
Spanish (es)
Inventor
Souza Richard Wilfred D
Sekhar Mitra
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter & Gamble filed Critical Procter & Gamble
Publication of PE56194A1 publication Critical patent/PE56194A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

SE REFIERE A UNA COMPOSICION QUE COMPRENDE: 1) ISOMEROS S(+) LIBRES DE SU ANTIPODA R(-) SELECCIONADOS DEL GRUPO DE: S(+) IBUPROFENO, S(+) FLURBIPROFENO, S(+) KETOPROFENO; POR SER LA FORMA FARMACOLOGICAMENTE ACTIVA CONTRA EL DOLOR Y LA INFLAMACION, Y 2) CAFEINA POR AUMENTAR LA RESPUESTA ANALGESICAIT REFERS TO A COMPOSITION THAT INCLUDES: 1) S (+) ISOMERS FREE OF THEIR ANTIPODA R (-) SELECTED FROM THE GROUP OF: S (+) IBUPROFENO, S (+) FLURBIPROFENO, S (+) KETOPROFEN; FOR BEING THE PHARMACOLOGICALLY ACTIVE FORM AGAINST PAIN AND INFLAMMATION, AND 2) CAFFEINE FOR INCREASING THE ANALGESIC RESPONSE

PE1993233164A 1992-12-21 1993-12-17 ANALGESIC COMPOSITION PE56194A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US99437192A 1992-12-21 1992-12-21

Publications (1)

Publication Number Publication Date
PE56194A1 true PE56194A1 (en) 1995-01-26

Family

ID=25540587

Family Applications (1)

Application Number Title Priority Date Filing Date
PE1993233164A PE56194A1 (en) 1992-12-21 1993-12-17 ANALGESIC COMPOSITION

Country Status (9)

Country Link
EP (1) EP0674517A1 (en)
JP (1) JPH08504818A (en)
CN (1) CN1094615A (en)
AU (1) AU672279B2 (en)
BR (1) BR9307697A (en)
CA (1) CA2149317A1 (en)
MX (1) MX9400038A (en)
PE (1) PE56194A1 (en)
WO (1) WO1994014449A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU7604194A (en) * 1993-09-07 1995-03-27 Procter & Gamble Company, The Compositions containing an amino acid salt of propionic acid non-steroidal anti-inflammatory agents and caffeine
CA2227958A1 (en) * 1995-07-28 1997-02-13 Sekhar Mitra Compositions containing analgesics and antihistamines and methods for treating respiratory disorders
JPH0987174A (en) * 1995-09-26 1997-03-31 Kobayashi Pharmaceut Co Ltd Analgesic and anti-inflammatory composition
US6211246B1 (en) * 1999-06-10 2001-04-03 Mcneil-Ppc, Inc. Rapidly absorbed liquid compositions
US7863287B2 (en) * 2002-12-18 2011-01-04 Wyeth Llc Compositions of non-steroidal anti-inflammatory drugs, decongestants and anti-histamines
PL2012763T3 (en) * 2006-04-28 2011-08-31 Gruenenthal Gmbh Pharmaceutical combination comprising 3- (3-dimethylamin0-1-ethyl-2-methyl-pr0pyl) -phenol and an nsaid

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4486436A (en) * 1982-07-22 1984-12-04 Analgesic Associates Analgesic and anti-inflammatory compositions comprising caffeine and methods of using same
US4420483A (en) * 1982-07-22 1983-12-13 Richardson-Vicks, Inc. Analgesic and anti-inflammatory compositions comprising ibuprofen and methods of using same
US4851444A (en) * 1987-07-10 1989-07-25 Analgesic Associates Onset-hastened/enhanced analgesia
WO1991006295A1 (en) * 1989-11-06 1991-05-16 Sepracor, Inc. Analgesic composition containing optically pure s(+) flurbiprofen
AU8764191A (en) * 1990-09-28 1992-04-28 Mcneill-Ppc Inc. Ibuprofen-antihistamine combinations

Also Published As

Publication number Publication date
EP0674517A1 (en) 1995-10-04
CN1094615A (en) 1994-11-09
AU672279B2 (en) 1996-09-26
BR9307697A (en) 1999-05-25
CA2149317A1 (en) 1994-07-07
JPH08504818A (en) 1996-05-28
AU5899394A (en) 1994-07-19
WO1994014449A1 (en) 1994-07-07
MX9400038A (en) 1994-07-29

Similar Documents

Publication Publication Date Title
ATE41739T1 (en) SOLID ORAL DOSAGE FORMULATIONS OF CONSTANT RELEASE RATE CARDIOVASCULAR AGENTS.
ES2192234T3 (en) PARENTERAL PHARMACEUTICAL COMPOSITIONS CONTAINING SALTS OF 2-ARILPROPIONIC ACIDS.
NO179250C (en) Analogous Process for Preparation of Therapeutically Active (+) - (2,3-Dimethoxyphenyl) -1- [2- (4-Fluorophenyl) Ethyl α-4-Piperidinemethanol
ECSP941104A (en) DERIVATIVES OF 2,6 DIAMINOPURINE, PROCEDURE FOR ITS PREPARATION AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM
IT1206341B (en) PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF ACUTE MYOCARDIUM ISCHHEMIA.
DK0535327T3 (en) Pharmaceutical preparation containing felbinac
AR064895A2 (en) PHARMACEUTICAL COMPOSITION ANHIDRA FOR THE TREATMENT OF HISTAMINE INDUCED DISORDERS
ES2122283T3 (en) INHIBITION OF HAIR GROWTH.
YU49026B (en) THE USE OF 17 ß -(N-TERT-BUTYLCARBAMOYIL)-4-AZA-5-ALPHA-ANDROST-1-ENE-3-ONE FOR THE PREPARATION OF A MEDICAMENT FOR THE TREATMENT OF ANDROGENIC ALOPECIA
ES2040106T3 (en) UTILIZATION OF ACETYL D-CARNITINE IN THE THERAPEUTIC TREATMENT OF GLAUCOMA.
ES2171933T3 (en) ANDROSTENO DERIVATIVES.
BR0013935A (en) Optically active isomers of ketotifen and therapeutically active metabolites thereof
MX9305248A (en) DIARILPIPERAZINOACETAMIDA COMPOUNDS.
MC2078A1 (en) USE OF ALEZASTINE AS AN ACTIVE INGREDIENT AGAINST PSORIASIS AND INFLAMMATORY DISEASES
ATE15596T1 (en) PHARMACEUTICAL AGENT.
ES2173858T3 (en) ANALOGS OF HUPERZINA A.
IT1170214B (en) PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF PERIPHERAL ARTERIOPATHIES
YU49215B (en) The use of flupirtine to prepare a medicament for the treatment of neurodegenerative diseases
MX9304564A (en) COMBINATIONS OF MUSCLE RELAXANT-IBUPROFEN.
ES2161292T3 (en) ORAL HYGIENE COMPOSITION.
PE56194A1 (en) ANALGESIC COMPOSITION
ES2054333T3 (en) DOSAGE FORM TO ADMINISTER A CALCIUM ANTAGONIST.
ES2094357T3 (en) NEW HETERO-CYCLIC CARBOXYL ACIDS.
AR001765A1 (en) A prolonged release formulation a procedure for its preparation a crystalline form of cisapride- (l) -tartrate and a drug useful for the treatment of gastrointestinal disorders
FR2434804A1 (en) N-PHENYL-INDOLIN DERIVATIVES, THEIR PREPARATION AND THEIR APPLICATION AS MEDICAMENTS

Legal Events

Date Code Title Description
FG Grant, registration
FD Application declared void or lapsed